{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:29:18Z","timestamp":1787502558749,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["FT220100010"],"award-info":[{"award-number":["FT220100010"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["DP230100079"],"award-info":[{"award-number":["DP230100079"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["CE200100029"],"award-info":[{"award-number":["CE200100029"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","award":["CE200100012"],"award-info":[{"award-number":["CE200100012"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005156","name":"Alexander von Humboldt-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bmcl.2025.130176","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T20:39:04Z","timestamp":1741725544000},"page":"130176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Synthesis, screening and validation of cysteine-reactive fragments as chikungunya virus protease inhibitors"],"prefix":"10.1016","volume":"122","author":[{"given":"Junming","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Illingworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Ullrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pritha","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Ton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin J.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Nitsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bmcl.2025.130176_bb0005","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/S1473-3099(20)30491-6","article-title":"Arthritogenic alphaviruses: epidemiological and clinical perspective on emerging arboviruses","volume":"21","author":"Zaid","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130176_bb0010","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3390\/microorganisms7050133","article-title":"Arthritogenic alphaviruses: a worldwide emerging threat?","volume":"7","author":"Levi","year":"2019","journal-title":"Microorganisms"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130176_bb0015","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1071\/RS23014","article-title":"Targeting the proteases of arboviruses with cyclic and bicyclic peptides","volume":"135","author":"Nitsche","year":"2023","journal-title":"Proc R Soc Vic"},{"key":"10.1016\/j.bmcl.2025.130176_bb0020","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.antiviral.2015.07.002","article-title":"Chikungunya virus pathogenesis: from bedside to bench","volume":"121","author":"Couderc","year":"2015","journal-title":"Antivir Res"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130176_bb0025","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1016\/S1473-3099(16)30385-1","article-title":"Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen","volume":"17","author":"Burt","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130176_bb0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41572-023-00429-2","article-title":"Chikungunya fever","volume":"9","author":"Bartholomeeusen","year":"2023","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130176_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010069","article-title":"The global epidemiology of chikungunya from 1999 to 2020: a systematic literature review to inform the development and introduction of vaccines","volume":"16","author":"Bettis","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130176_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007213","article-title":"Global expansion and redistribution of Aedes-borne virus transmission risk with climate change","volume":"13","author":"Ryan","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"issue":"S6","key":"10.1016\/j.bmcl.2025.130176_bb0045","doi-asserted-by":"crossref","first-page":"S414","DOI":"10.1093\/infdis\/jiac326","article-title":"Developing a prototype pathogen plan and research priorities for the alphaviruses","volume":"228","author":"Powers","year":"2023","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bmcl.2025.130176_bb0050","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jcv.2014.08.032","article-title":"Chikungunya, a paradigm of neglected tropical disease that emerged to be a new health global risk","volume":"64","author":"Rougeron","year":"2015","journal-title":"J Clin Virol"},{"key":"10.1016\/j.bmcl.2025.130176_bb0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.coviro.2020.06.005","article-title":"Revisiting an old friend: new findings in alphavirus structure and assembly","volume":"45","author":"Button","year":"2020","journal-title":"Curr Opin Virol"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130176_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009055","article-title":"Measuring the global burden of chikungunya and Zika viruses: a systematic review","volume":"15","author":"Puntasecca","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bmcl.2025.130176_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105476","article-title":"The life cycle of the alphaviruses: from an antiviral perspective","volume":"209","author":"Skidmore","year":"2023","journal-title":"Antivir Res"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130176_bb0070","article-title":"Drugs targeting structural and nonstructural proteins of the chikungunya virus: a review","volume":"262","author":"Wang","year":"2024","journal-title":"Int J Biol Macromol"},{"issue":"16","key":"10.1016\/j.bmcl.2025.130176_bb0075","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1016\/j.bmc.2017.06.049","article-title":"The medicinal chemistry of chikungunya virus","volume":"25","author":"da Silva-J\u00fanior","year":"2017","journal-title":"Bioorg Med Chem"},{"issue":"7","key":"10.1016\/j.bmcl.2025.130176_bb0080","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2217\/fmb.09.59","article-title":"A structural and functional perspective of alphavirus replication and assembly","volume":"4","author":"Jose","year":"2009","journal-title":"Future Microbiol"},{"issue":"9","key":"10.1016\/j.bmcl.2025.130176_bb0085","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1080\/17460441.2019.1629413","article-title":"Chikungunya virus drug discovery: still a long way to go?","volume":"14","author":"P\u00e9rez-P\u00e9rez","year":"2019","journal-title":"Expert Opin Drug Discov"},{"issue":"48","key":"10.1016\/j.bmcl.2025.130176_bb0090","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.add2536","article-title":"Molecular architecture of the chikungunya virus replication complex","volume":"8","author":"Tan","year":"2022","journal-title":"Sci Adv"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130176_bb0095","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20150086","article-title":"Full length and protease domain activity of chikungunya virus nsP2 differ from other alphavirus nsP2 proteases in recognition of small peptide substrates","volume":"35","author":"Saisawang","year":"2015","journal-title":"Biosci Rep"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130176_bb0100","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/med.21475","article-title":"Proteases and protease inhibitors in infectious diseases","volume":"38","author":"Agbowuro","year":"2018","journal-title":"Med Res Rev"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130176_bb0105","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3390\/v16030366","article-title":"Recent advances on targeting proteases for antiviral development","volume":"16","author":"Borges","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.bmcl.2025.130176_bb0110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.antiviral.2015.06.017","article-title":"Towards antivirals against chikungunya virus","volume":"121","author":"Abdelnabi","year":"2015","journal-title":"Antivir Res"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130176_bb0115","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/pathogens8030128","article-title":"Targeting the nsp2 cysteine protease of chikungunya virus using FDA approved library and selected cysteine protease inhibitors","volume":"8","author":"Kumar","year":"2019","journal-title":"Pathogens"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130176_bb0120","doi-asserted-by":"crossref","first-page":"10831","DOI":"10.1038\/s41598-018-29024-2","article-title":"Development of nsP2 protease based cell free high throughput screening assay for evaluation of inhibitors against emerging chikungunya virus","volume":"8","author":"Saha","year":"2018","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.bmcl.2025.130176_bb0125","doi-asserted-by":"crossref","first-page":"7382","DOI":"10.1128\/AAC.01421-16","article-title":"Design and validation of novel chikungunya virus protease inhibitors","volume":"60","author":"Das","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmcl.2025.130176_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmgm.2015.01.001","article-title":"Identification of chikungunya virus nsP2 protease inhibitors using structure-base approaches","volume":"57","author":"Nguyen","year":"2015","journal-title":"J Mol Graph Model"},{"issue":"16","key":"10.1016\/j.bmcl.2025.130176_bb0135","doi-asserted-by":"crossref","first-page":"10884","DOI":"10.1021\/acsomega.1c00625","article-title":"Novel analogues of the chikungunya virus protease inhibitor: molecular design, synthesis, and biological evaluation","volume":"6","author":"Ivanova","year":"2021","journal-title":"ACS Omega"},{"issue":"42","key":"10.1016\/j.bmcl.2025.130176_bb0140","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2409166121","article-title":"Identification of a cell-active chikungunya virus nsP2 protease inhibitor using a covalent fragment-based screening approach","volume":"121","author":"Merten","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130176_bb0145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.chembiol.2018.10.001","article-title":"Fragment-based drug discovery: advancing fragments in the absence of crystal structures","volume":"26","author":"Erlanson","year":"2019","journal-title":"Cell Chem Biol"},{"issue":"9","key":"10.1016\/j.bmcl.2025.130176_bb0150","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrd.2016.109","article-title":"Twenty years on: the impact of fragments on drug discovery","volume":"15","author":"Erlanson","year":"2016","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"10.1016\/j.bmcl.2025.130176_bb0155","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.drudis.2020.03.016","article-title":"Covalent fragment libraries in drug discovery","volume":"25","author":"Keeley","year":"2020","journal-title":"Drug Discov Today"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130176_bb0160","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1039\/D0CB00222D","article-title":"Fragment-based covalent ligand discovery","volume":"2","author":"Lu","year":"2021","journal-title":"RSC Chem Biol"},{"issue":"18","key":"10.1016\/j.bmcl.2025.130176_bb0165","doi-asserted-by":"crossref","first-page":"7590","DOI":"10.1021\/jm5006918","article-title":"Promiscuity and selectivity in covalent enzyme inhibition: a systematic study of electrophilic fragments","volume":"57","author":"J\u00f6st","year":"2014","journal-title":"J Med Chem"},{"issue":"15","key":"10.1016\/j.bmcl.2025.130176_bb0170","doi-asserted-by":"crossref","first-page":"8408","DOI":"10.1021\/acs.jmedchem.0c00754","article-title":"The most common functional groups in bioactive molecules and how their popularity has evolved over time","volume":"63","author":"Ertl","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130176_bb0175","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ijbiomac.2018.05.007","article-title":"Crystal structure of chikungunya virus nsP2 cysteine protease reveals a putative flexible loop blocking its active site","volume":"116","author":"Narwal","year":"2018","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.bmcl.2025.130176_bb0180","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.pharmthera.2016.07.003","article-title":"The ways and means of fragment-based drug design","volume":"167","author":"Doak","year":"2016","journal-title":"Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130176_bb0185","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1021\/acs.jmedchem.3c02222","article-title":"A novel NMR-based protocol to screen ultralow molecular weight fragments","volume":"67","author":"Favaro","year":"2024","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130176_bb0190","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1038\/s41598-020-60747-3","article-title":"High-throughput screening to predict chemical-assay interference","volume":"10","author":"Borrel","year":"2020","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.bmcl.2025.130176_bb0195","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41570-024-00593-3","article-title":"Tackling assay interference associated with small molecules","volume":"8","author":"Tan","year":"2024","journal-title":"Nat Rev Chem"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130176_bb0200","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cbpa.2010.03.020","article-title":"Apparent activity in high-throughput screening: origins of compound-dependent assay interference","volume":"14","author":"Thorne","year":"2010","journal-title":"Curr Opin Chem Biol"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130176_bb0205","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ab.2007.07.008","article-title":"Rapid determination of enzyme kinetics from fluorescence: overcoming the inner filter effect","volume":"371","author":"Palmier","year":"2007","journal-title":"Anal Biochem"},{"key":"10.1016\/j.bmcl.2025.130176_bb0210","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.molstruc.2014.03.028","article-title":"Inner filter effects and other traps in quantitative spectrofluorimetric measurements: origins and methods of correction","volume":"1077","author":"Credi","year":"2014","journal-title":"J Mol Struct"},{"issue":"35","key":"10.1016\/j.bmcl.2025.130176_bb0215","doi-asserted-by":"crossref","first-page":"13036","DOI":"10.1021\/acs.analchem.3c01295","article-title":"Reducing the inner filter effect in microplates by increasing absorbance? Linear fluorescence in highly concentrated fluorophore solutions in the presence of an added absorber","volume":"95","author":"Friganovi\u0107","year":"2023","journal-title":"Anal Chem"},{"key":"10.1016\/j.bmcl.2025.130176_bb0220","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-1-62703-484-5_18","article-title":"Fluorimetric and HPLC-based dengue virus protease assays using a FRET substrate","author":"Nitsche","year":"2013","journal-title":"Antiviral Methods and Protocols"},{"issue":"7","key":"10.1016\/j.bmcl.2025.130176_bb0225","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130176_bb0230","doi-asserted-by":"crossref","first-page":"1379518","DOI":"10.3389\/fchem.2024.1379518","article-title":"Fragment-based drug discovery for disorders of the central nervous system: designing better drugs piece by piece","volume":"12","author":"Chan","year":"2024","journal-title":"Front Chem"},{"issue":"36","key":"10.1016\/j.bmcl.2025.130176_bb0235","doi-asserted-by":"crossref","first-page":"12624","DOI":"10.1021\/ja505194w","article-title":"Design of reversible, cysteine-targeted Michael acceptors guided by kinetic and computational analysis","volume":"136","author":"Krishnan","year":"2014","journal-title":"J Am Chem Soc"},{"issue":"6","key":"10.1016\/j.bmcl.2025.130176_bb0240","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00044-023-03065-3","article-title":"An update on the discovery and development of reversible covalent inhibitors","volume":"32","author":"Faridoon","year":"2023","journal-title":"Med Chem Res"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130176_bb0245","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1021\/acs.jmedchem.6b00788","article-title":"Covalent modifiers: A chemical perspective on the reactivity of \u03b1,\u03b2-unsaturated carbonyls with thiols via hetero-Michael addition reactions","volume":"60","author":"Jackson","year":"2016","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130176_bb0250","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/mr.58.3.491-562.1994","article-title":"The alphaviruses: gene expression, replication, and evolution","volume":"58","author":"Strauss","year":"1994","journal-title":"Microbiol Rev"},{"issue":"2","key":"10.1016\/j.bmcl.2025.130176_bb0255","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0006-291X(67)80055-X","article-title":"On the size of the active site in proteases. I Papain","volume":"27","author":"Schechter","year":"1967","journal-title":"Biochem Biophys Res Commun"},{"issue":"19","key":"10.1016\/j.bmcl.2025.130176_bb0260","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202200327","article-title":"SARS-CoV-2 papain-like protease: structure, function and inhibition","volume":"23","author":"Ullrich","year":"2022","journal-title":"ChemBioChem"},{"issue":"42","key":"10.1016\/j.bmcl.2025.130176_bb0265","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd4596","article-title":"Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: a framework for anti\u2013COVID-19 drug design","volume":"6","author":"Rut","year":"2020","journal-title":"Sci Adv"},{"issue":"12","key":"10.1016\/j.bmcl.2025.130176_bb0270","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/s41573-022-00542-z","article-title":"Advances in covalent drug discovery","volume":"21","author":"Boike","year":"2022","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"10.1016\/j.bmcl.2025.130176_bb0275","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1039\/D2MD00216G","article-title":"Advanced approaches of developing targeted covalent drugs","volume":"13","author":"Gai","year":"2022","journal-title":"RSC Med Chem"},{"issue":"7","key":"10.1016\/j.bmcl.2025.130176_bb0280","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1039\/D1MD00068C","article-title":"Recent advances in the development of covalent inhibitors","volume":"12","author":"Kim","year":"2021","journal-title":"RSC Med Chem"},{"issue":"23","key":"10.1016\/j.bmcl.2025.130176_bb0285","doi-asserted-by":"crossref","first-page":"9171","DOI":"10.1021\/acs.jmedchem.5b01018","article-title":"Systematic study of the glutathione (GSH) reactivity of N-arylacrylamides: 1. Effects of aryl substitution","volume":"58","author":"Cee","year":"2015","journal-title":"J Med Chem"},{"issue":"20","key":"10.1016\/j.bmcl.2025.130176_bb0290","doi-asserted-by":"crossref","first-page":"11602","DOI":"10.1021\/acs.jmedchem.0c00749","article-title":"Systematic study of the glutathione reactivity of N-phenylacrylamides: 2. Effects of acrylamide substitution","volume":"63","author":"Birkholz","year":"2020","journal-title":"J Med Chem"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2500085X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X2500085X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:07:27Z","timestamp":1762344447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X2500085X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":58,"alternative-id":["S0960894X2500085X"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130176","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, screening and validation of cysteine-reactive fragments as chikungunya virus protease inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130176","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"130176"}}